The Global Biologics Contract Development Market was $6.12 Bn in 2020, and it is expected to reach $14.20 Bn by 2030. It is eventually growing at a commendable high compound of annual growth rate CAGR of 8.8% between 2020-2030. The Biologics contract development market is the type of organization that offers complete services from the cell line development to long-term biological commercial product supply. The service includes bioanalytical methods, upstream and downstream process, analytical, and cell lines. Government support, favorable rules and regulation, massive investment in the research centers, and increasing demand over the whole world are expected to drive the market growth of the biological contract development market during the forecast period. Now, moving forward, the robust demand for the Global Biologics Contract Development Market in the healthcare department is further estimated to create new necessities and augment the market of growth over the forecast period of 2020-2030.
Global Biologics Contract Development Segment Is Estimated to Witness Remarkable Growth
Source: SAI Research
The global Biologics Contract Development market is segmented into the source, product service, and disease indication. By Source, the global Biologics Contract Development market has been divided into Microbial, Mammalian, and Others. By Product Service Biologics Contract Development market has been bifurcated as Cell Line Development, Microbial, Mammalian, Others, Process Development, Upstream, Microbial, Mammalian, Others, Downstream, Impurity, isolation, & identification, Physicochemical characterization, Pharmaceutical analysis, Others, By Product, MABs, Recombinant proteins, and Others. By Disease Indication, the global Biologics Contract Development market is segmented as Oncology, Immunological disorders, Cardiovascular disorders, Hematological disorders, and Others.
By Region, North America is Holding the Major Market Share
The global Biologics Contract Development Market has been geographically segmented into North America, Asia Pacific, Latin America, Middle East, and Africa. In addition to this, North America is expected to exhibit considerable growth during the forecast period. However, this is attributed to increasing the investment and presence of local-global player and their efforts to obtain the new patents. Increasing outsourcing activities, a rising number of clinical trials, advanced methods and instruments, efficient experts are expected to boost the market growth in the forecast period. Apart from that, Asia pacific and others are also expected to drive the market growth in the forecast period.
Major Players in Global Biologics Contract Development Market
The report covers a detailed outlook of the company, and it includes the market share and company or industry profiles of key players operating in the global market. Key players in the report include WuXi Biologics, Abzena Ltd., Fujifilm Diosynth Biotechnologies, KBI Biopharma, AGC Biologics, SE Thermo Fisher (Patheon), LakePharma, Genscript Biotech Corporation, Bionova Scientific, Boehringer Ingelheim BioXcellence, STC Biologics, Inc., Thermo Fisher Scientific Inc., Catalent, Lonza Group, Recipharm AB among others.
The Global Biologics Contract Development Market Has Been Segmented into:
Global Biologics Contract Development Market: By Source
Global Biologics Contract Development Market: By Product Service
Global Biologics Contract Development Market: By Disease Indication
Global Biologics Contract Development Market: By Region